E
ME Therapeutics Holdings Inc. METX
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

11/30/2024 08/31/2024 05/31/2024 02/29/2024 11/30/2023
Net Income -917.80K -950.00K -1.01M -5.11M -5.03M
Total Depreciation and Amortization 7.60K 0.00 0.00 0.00 0.00
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 470.20K 512.50K 590.00K 4.71M 4.70M
Change in Net Operating Assets 45.70K -45.50K -28.50K -47.50K -58.90K
Cash from Operations -394.20K -482.90K -448.90K -452.20K -387.40K
Capital Expenditure -6.40K -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 0.00 558.20K 558.20K
Divestitures -- -- -- -- --
Other Investing Activities -7.90K -- -- -- --
Cash from Investing -14.30K -- 0.00 558.20K 558.20K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -45.40K -40.00K -40.00K -40.00K --
Issuance of Common Stock 1.56M 1.56M 1.67M 1.22M 115.50K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -7.50K -7.50K -- -- --
Cash from Financing 1.11M 1.12M 1.21M 879.40K 86.70K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 704.90K 634.50K 760.70K 985.50K 257.60K
Weiss Ratings